Vln. Murty et al., INHIBITION OF HELICOBACTER-PYLORI GLYCOSULFATASE ACTIVITY TOWARDS HUMAN GASTRIC SULFOMUCIN BY A GASTROPROTECTIVE AGENT, SULGLYCOTIDE, General pharmacology, 24(6), 1993, pp. 1463-1466
1. A glycosulfatase activity towards human gastric sulfomucin was iden
tified in the extracellular material elaborated by Helicobacter pylori
, a pathogen implicated in the etiology of gastric disease. 2. The pur
ified enzyme displayed an apparent molecular weight of 30 kDa, and exh
ibited maximum activity at pH 5.7 in the presence of 0.3% Triton X-100
and 100 mM CaCl2. 3. The H. pylori glycosulfatase activity towards hu
man gastric sulfomucin was inhibited by a gastroprotective agent, sulg
lycotide. The inhibitory effect was proportional to the concentration
of sulglycotide up to 20 mug/ml, at which a 98% decrease in mucin desu
lfation occurred. However, the drug lost the inhibitory effect followi
ng its chemical desulfation. 4. The results demonstrate that sulglycot
ide is a potent inhibitor of H. pylori glycosulfatase and, hence, may
be of value in the treatment of gastric disease associated with this b
acterial infection.